Filing Details
- Accession Number:
- 0001209191-21-023607
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-30 17:33:28
- Reporting Period:
- 2021-03-29
- Accepted Time:
- 2021-03-30 17:33:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Surgical & Medical Instruments & Apparatus (3841) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1434369 | Glenn Coleman | 1100 Campus Road Princeton NJ 08540 | Executive Vice President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-29 | 3,000 | $68.50 | 36,058 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-03-29 | 12,500 | $19.41 | 48,558 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-29 | 12,500 | $68.50 | 36,058 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-03-29 | 12,500 | $19.41 | 12,500 | $19.41 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
38,158 | 2022-05-02 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were affected pursuant to Rule 10b5-1 trading plans previously adopted by the reporting person.
- 25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 5/2/2014.
- This option was previously reported as covering 24,264 shares at an exercise price of $44.87 per share, but was adjusted pursuant to the antidilutionprovisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015.
- In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.